drugset / Trial / NCT02895035
Comparison of Epinephrine and Phenylephrine/Ketorolac With Regards to Pupil Size
RandomizedCrossoverDouble-blindOther
Summary
The objective of this study is to compare the maintenance of intraoperative mydriasis during cataract surgery between two drugs: epinephrine, which has routinely been used for decades, and Omidria, a newly FDA approved combination drug of phenylephrine and ketorolac. Patients undergoing cataract surgery that are enrolled in the trial will randomly receive one of the drugs in one eye, and the other eye will receive the drug during the subsequent cataract surgery.
Timeline
- Start
- 2016-09-01
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Epinephrine | Other / unclassified | — | Other |
| Comparator | Ketorolac | Other / unclassified | 3 % | Other |
| Comparator | Phenylephrine | Small molecule | 1 % | Other |